SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Results of Operations and Financial Condition
Item 2.02 99.1 Press Release dated November 11, 2020 (furnished herewith) 99.2 Transcript of Conference Call to Review Earnings on November 11, 2020 (furnished herewith) 99.3 Press Release dated November 11, 2020 (furnished herewith)

SenesTech, Inc. Exhibit
EX-99.1 2 ea129775ex99-1_senestech.htm PRESS RELEASE DATED NOVEMBER 11,…
To view the full exhibit click here

About SenesTech, Inc. (NASDAQ:SNES)

SenesTech, Inc. is a platform biotechnology company. The Company is engaged in developing a technology for managing animal pest populations through fertility control. Its approach is designed to manage food security and manage infrastructure damage, disease outbreaks, environmental contamination and other costs associated with rodent infestations. Its fertility control product candidate, ContraPest, will be marketed for use in controlling rat populations. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. The Company applies its technology to manage rats in urban and agricultural settings. It has a pipeline of fertility control and animal health products, which include ContraPest, Plant-based fertility control, Feral animal fertility control, Boar taint, and Non-Surgical Spay and Neutering.